| scholarly article | Q13442814 |
| P2093 | author name string | Yasuhiko Tabata | |
| Yoshiaki Fukunishi | |||
| P2860 | cites work | Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells | Q28572800 |
| Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis | Q33902258 | ||
| Molecular diversity of heparan sulfate | Q34310374 | ||
| Heparan sulfate: growth control with a restricted sequence menu | Q34328757 | ||
| Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2 | Q35108285 | ||
| Interaction of heparins with fibroblast growth factors: conformational aspects | Q36879372 | ||
| Secreted proteoglycans directly mediate human embryonic stem cell-basic fibroblast growth factor 2 interactions critical for proliferation | Q37021165 | ||
| Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? | Q37407186 | ||
| Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. | Q38288315 | ||
| Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor | Q38314305 | ||
| Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4 | Q38314349 | ||
| Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor | Q38327052 | ||
| Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate | Q38328648 | ||
| Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 | ||
| Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy | Q38357778 | ||
| Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. | Q40223688 | ||
| Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity | Q41211589 | ||
| Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. | Q42804006 | ||
| Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. | Q45937934 | ||
| Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. | Q50887542 | ||
| Effects of heparin and its 6-O-and 2-O-desulfated derivatives with low anticoagulant activity on proliferation of human neural stem/progenitor cells. | Q51335078 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| Differential transport kinetics of chondroitin sulfate and dermatan sulfate proteoglycan by monkey aorta smooth muscle cells | Q68077269 | ||
| Basic fibroblast growth factor stimulates phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells | Q71934336 | ||
| Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells | Q71969111 | ||
| Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2 | Q80150041 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | morphogenesis | Q815547 |
| P304 | page(s) | 58-62 | |
| P577 | publication date | 2018-06-01 | |
| P1433 | published in | Regenerative Therapy | Q50817062 |
| P1476 | title | Osteogenic differentiation enhances the MC3T3-E1 secretion of glycosaminoglycans with an affinity for basic fibroblast growth factor and bone morphogenetic protein-2 | |
| P478 | volume | 8 |
Search more.